Enovis CORP
ENOV- Exchange
- NYSE
- Industry
- Orthopedic, Prosthetic & Surgical Appliances & Supplies
- SEC CIK
- 0001420800
In the last 90 days, Enovis CORP insiders filed 7 open-market purchases and 0 sales; 243 institutions reported holding it in 13F filings for Q3 2026, worth $1.28B in total; Southeastern Asset Management (Longleaf) is the only superinvestor holding it.
- Currency
- USD
- Source
- SEC XBRL data (10-K, 10-Q, 20-F, 40-F)
- Updated
- Nov 8, 2026, 10:48 PM ET
Revenue flow, FY2025
Where the revenue went in FY2025, from the income statement below. Green is profit; orange is costs, expenses and taxes. Percentages are shares of revenue; hover over a band or a bar for the exact amount.
Net loss for FY2025: $1.18B (52.7% of revenue).
Income statement
Each column is one fiscal year, newest first.
| Line item | FY2025 | FY2024 | FY2023 | FY2022 | FY2021 |
|---|---|---|---|---|---|
| Period end | Dec 31, 2025 | Dec 31, 2024 | Dec 31, 2023 | Dec 31, 2022 | Dec 31, 2021 |
| Filing | 10-K | 10-K | 10-K | 10-K | 10-K |
| Reported | Feb 26, 2026 | Feb 26, 2025 | Feb 22, 2024 | Feb 23, 2023 | Feb 22, 2022 |
| Revenue | $2.25B | $2.11B | $1.71B | $1.56B | $3.85B |
| Cost of revenue | $902.8M | $926.9M | $716.4M | $693.7M | $2.24B |
| Gross profit | $1.35B | $1.18B | $990.8M | $869.4M | $1.61B |
| Research and development | $120.3M | $91.3M | $75.3M | $60.8M | – |
| Selling, general and administrative | $1.07B | $1.03B | $830.3M | $772.9M | $1.33B |
| Operating income | -$1.12B | -$775.7M | -$65.7M | -$71.2M | $256.6M |
| Interest expense | $34.8M | $57.1M | $19.7M | $24.1M | $72.6M |
| Income tax | $22.3M | $4.49M | -$13.3M | $36.1M | $66.7M |
| Net income | -$1.18B | -$825.5M | -$33.3M | -$13.3M | $71.7M |
| EPS, basic | $-20.75 | $-14.93 | $-0.61 | $-0.25 | $0.47 |
| EPS, diluted | $-20.75 | $-14.93 | $-0.61 | $-0.25 | $0.46 |
| Weighted shares, basic | 57.1M | 55.3M | 54.5M | 54.1M | 153.4M |
| Weighted shares, diluted | 57.1M | 55.3M | 54.5M | 54.1M | 155.5M |
| Margins and growth | |||||
| Gross margin | 59.8% | 56.0% | 58.0% | 55.6% | 41.9% |
| Operating margin | -50.0% | -36.8% | -3.8% | -4.6% | 6.7% |
| Net margin | -52.7% | -39.2% | -1.9% | -0.9% | 1.9% |
| Revenue growth, year over year | +6.7% | +23.5% | +9.2% | −59.4% | +25.5% |
| Net income growth, year over year | – | – | – | −118.5% | +68.1% |
Balance sheet
Each column is one fiscal year, newest first.
| Line item | FY2025 | FY2024 | FY2023 | FY2022 | FY2021 |
|---|---|---|---|---|---|
| Period end | Dec 31, 2025 | Dec 31, 2024 | Dec 31, 2023 | Dec 31, 2022 | Dec 31, 2021 |
| Filing | 10-K | 10-K | 10-K | 10-K | 10-K |
| Reported | Feb 26, 2026 | Feb 26, 2025 | Feb 22, 2024 | Feb 23, 2023 | Feb 22, 2022 |
| Cash and equivalents | $36.4M | $48.2M | $36.2M | $24.3M | $719.4M |
| Accounts receivable | $442.8M | $407.0M | $291.5M | $267.4M | $638.7M |
| Inventory | $584.4M | $547.1M | $468.8M | $426.6M | $776.3M |
| Total current assets | $1.21B | $1.15B | $896.5M | $795.0M | $2.30B |
| Property, plant and equipment | $507.1M | $404.5M | $270.8M | $236.7M | $521.4M |
| Goodwill | $718.3M | $1.69B | $2.06B | $1.98B | $3.47B |
| Intangible assets | $1.24B | $1.32B | $1.13B | $1.11B | $1.68B |
| Total assets | $3.83B | $4.72B | $4.51B | $4.27B | $8.52B |
| Accounts payable | $187.5M | $179.1M | $132.5M | $135.6M | $504.2M |
| Short-term debt | $35.0M | $20.0M | $0 | $219.3M | $8.31M |
| Total current liabilities | $598.5M | $529.0M | $369.6M | $565.2M | $1.02B |
| Long-term debt | $1.26B | $1.31B | $466.2M | $40.0M | $2.08B |
| Total liabilities | $2.34B | $2.15B | $1.09B | $823.4M | $3.85B |
| Shareholders' equity | $1.49B | $2.56B | $3.42B | $3.45B | $4.66B |
Cash flow statement
Each column is one fiscal year, newest first. Free cash flow is operating cash flow minus capital expenditures.
| Line item | FY2025 | FY2024 | FY2023 | FY2022 | FY2021 |
|---|---|---|---|---|---|
| Period end | Dec 31, 2025 | Dec 31, 2024 | Dec 31, 2023 | Dec 31, 2022 | Dec 31, 2021 |
| Filing | 10-K | 10-K | 10-K | 10-K | 10-K |
| Reported | Feb 26, 2026 | Feb 26, 2025 | Feb 22, 2024 | Feb 23, 2023 | Feb 22, 2022 |
| Operating cash flow | $217.3M | $113.5M | $135.0M | -$55.9M | $356.1M |
| Capital expenditures | $197.4M | $180.7M | $122.2M | $105.5M | $104.2M |
| Free cash flow | $19.9M | -$67.2M | $12.8M | -$161.3M | $251.9M |
| Depreciation and amortization | $1.34B | $927.8M | $217.1M | $203.0M | $262.9M |
| Stock-based compensation | $32.9M | $29.7M | $34.1M | $39.0M | $35.4M |
| Share buybacks | $3.50M | $4.77M | – | – | – |
| Investing cash flow | -$179.4M | -$955.5M | -$242.5M | -$176.4M | -$320.5M |
| Financing cash flow | -$52.4M | $846.8M | $127.8M | -$465.1M | $584.9M |
| Net change in cash | -$11.8M | $3.33M | $20.5M | -$695.1M | $618.3M |
| Ratio | |||||
| Stock-based compensation, % of revenue | 1.5% | 1.4% | 2.0% | 2.5% | 0.9% |
Shares outstanding
Common shares outstanding as stated on the cover of each 10-K and 10-Q. The date is the cover date, not the period end; a rising count means dilution.
Notes and known gaps
How these numbers are put together, and what they can't tell you.
- Numbers come from the XBRL data in each period's original 10-K, 10-Q, 20-F or 40-F, or its amendment. They are shown as filed: later filings don't restate earlier periods here.
- Reported is the filing date of the first 8-K with Item 2.02 (results of operations) after the period ended, no later than the 10-Q or 10-K and within 120 days. Companies that release results only in the 10-Q, and foreign companies, which use Form 6-K, have none.
Known gaps
- Foreign companies that file Form 20-F or 40-F have annual statements only: their quarterly results are furnished on Form 6-K, which has no XBRL data.
- EPS and share counts are as reported at the time, not adjusted for later stock splits.
- For ADRs, EPS is per ordinary share, not per ADS (one TSMC ADS is five ordinary shares).
- For banks, revenue may be interest income only, depending on how the bank tags its filings; cost of revenue and gross profit are usually blank.
- Companies with several share classes, such as Berkshire Hathaway, may have no EPS and no cover share count.
- Depreciation and amortization is missing for some companies that report it under their own XBRL tags.